Terms: = Colorectal cancer AND MLH1, COCA2, 4292, ENSG00000076242, hMLH1, FCC2, HNPCC2, P40692, MGC5172, HNPCC
4553 results:
1. Prognostic implications of immunohistochemistry in patients with endometrial cancer.
Anca-Stanciu MB; Manu A; Olinca MV; Coroleucă BC; Comandaşu DE; Coroleucă CA; Maier C; Brătilă E
Rom J Morphol Embryol; 2024; 65(2):185-193. PubMed ID: 39020532
[TBL] [Abstract] [Full Text] [Related]
2. Exome Sequencing Identifies Carriers of the Autosomal Dominant cancer Predisposition Disorders Beyond Current Practice Guideline Recommendations.
Samadder NJ; Gay E; Lindpere V; Bublitz ML; Bandel LA; Armasu SM; Vierkant RA; Ferber MJ; Klee EW; Larson NB; Kruisselbrink TM; Egan JB; Kemppainen JL; Bidwell JS; Anderson JL; McAllister TM; Walker TS; Kunze KL; Golafshar MA; Klint MA; Presutti RJ; Bobo WV; Sekulic A; Summer-Bolster JM; Willman CL; Lazaridis KN
JCO Precis Oncol; 2024 Jul; 8():e2400106. PubMed ID: 39013133
[TBL] [Abstract] [Full Text] [Related]
3. Analysis of clinical characteristics of mismatch repair status in colorectal cancer: a multicenter retrospective study.
Mao J; He Y; Chu J; Hu B; Yao Y; Yan Q; Han S
Int J Colorectal Dis; 2024 Jul; 39(1):100. PubMed ID: 38967814
[TBL] [Abstract] [Full Text] [Related]
4. [Clinicopathological features and prognosis of sporadic mismatch repair deficient colorectal cancer].
Wang H; Hong RP; Chen JC; Wang J; Zhang ZJ; Ren XY; Wu HW; Liang ZY
Zhonghua Bing Li Xue Za Zhi; 2024 Jul; 53(7):702-708. PubMed ID: 38955702
[No Abstract] [Full Text] [Related]
5. Large-scale external validation and meta-analysis of gene methylation biomarkers in tumor tissue for colorectal cancer prognosis.
Yuan T; Wankhede D; Edelmann D; Kather JN; Tagscherer KE; Roth W; Bewerunge-Hudler M; Brobeil A; Kloor M; Bläker H; Brenner H; Hoffmeister M
EBioMedicine; 2024 Jul; 105():105223. PubMed ID: 38917511
[TBL] [Abstract] [Full Text] [Related]
6. Predictors for dMMR colorectal cancer in patients with serrated lesions and polyps - A register-based cohort study.
Andrea MK; Jepsen RK; Klein MF; Gögenur I; Kuhlmann TP
Cancer Epidemiol; 2024 Aug; 91():102601. PubMed ID: 38905781
[TBL] [Abstract] [Full Text] [Related]
7. Erk Inhibition as a Promising Therapeutic Strategy for High IL-8-Secreting and Low SPTAN1-Expressing colorectal cancer.
Meier C; La Rocca G; Nawrot V; Fißlthaler B; Overby SJ; Hourfar K; Plotz G; Seidl C; Ziegler P; Wild P; Zeuzem S; Brieger J; Jäger E; Battmann A; Brieger A
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891846
[TBL] [Abstract] [Full Text] [Related]
8. Unmasking early colorectal cancer clues: in silico and in vitro investigation of downregulated IGF2, SOCS1, mlh1, and CACNA1G in SSA polyps.
Mirbahari SN; Fatemi N; Savabkar S; Chaleshi V; Zali N; Taleghani MY; Mirzaei E; Rejali L; Moghadam PK; Mojarad EN
Mol Biol Rep; 2024 Jun; 51(1):764. PubMed ID: 38874740
[TBL] [Abstract] [Full Text] [Related]
9. Association between gut microbiota and CpG island methylator phenotype in colorectal cancer.
Park PH; Keith K; Calendo G; Jelinek J; Madzo J; Gharaibeh RZ; Ghosh J; Sapienza C; Jobin C; Issa JJ
Gut Microbes; 2024; 16(1):2363012. PubMed ID: 38860458
[TBL] [Abstract] [Full Text] [Related]
10. Tumor-infiltrating lymphocytes, PD-L1, and MMR-deficiency combined characterization may identify subgroups of rectal cancer patients who would benefit from immunotherapy.
Giatromanolaki A; Kavazis C; Gkegka AG; Kouroupi M; Tsaroucha A; Pitiakoudis M; Koukourakis MI
Immunobiology; 2023 Nov; 228(6):152756. PubMed ID: 38860277
[TBL] [Abstract] [Full Text] [Related]
11. Prevalence of Potentially Pathogenic Germline Variants Among Adult Patients in the Philippines With Solid Malignancies Who Underwent Tumor Genomic Profiling.
Franco PI; Andal JJ; Ang DC; Que FV
JCO Glob Oncol; 2024 Jun; 10():e2400019. PubMed ID: 38843470
[TBL] [Abstract] [Full Text] [Related]
12. Functional analysis of MMR gene VUS from potential Lynch syndrome patients.
Mahdouani M; Zhuri D; Sezginer Guler H; Hmida D; Sana M; Azaza M; Ben Said M; Masmoudi S; Hmila F; Youssef S; Ben Sghaier R; Brieger A; Zeuzem S; Saad A; Gurkan H; Yalcintepe S; Gribaa M; Plotz G
PLoS One; 2024; 19(6):e0304141. PubMed ID: 38843250
[TBL] [Abstract] [Full Text] [Related]
13. Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer.
Yang L; Yi J; He W; Kong P; Xie Q; Jin Y; Xiong Z; Xia L
Br J Cancer; 2024 Jul; 131(2):334-346. PubMed ID: 38796599
[TBL] [Abstract] [Full Text] [Related]
14. Assessing Mismatch Repair Expression by Immunohistochemistry in colorectal Adenocarcinoma -Insight from a Tertiary Care Centre.
Lakhe R; Doshi R; Doshi P; Patil A; Nimbargi R
Gulf J Oncolog; 2024 May; 1(45):35-41. PubMed ID: 38774931
[TBL] [Abstract] [Full Text] [Related]
15. The Relationship of Microsatellite Instability with BRAF and p53 Mutations and Histopathological Parameters in colorectal Adenocarcinoma.
Gündoğar Ö; Bektaş S; Yıldırım E; Gönüllü D
Ann Ital Chir; 2024; 95(2):181-191. PubMed ID: 38684491
[TBL] [Abstract] [Full Text] [Related]
16. Liposome Nanomedicine Based on Tumor Cell Lysate Mitigates the Progression of Lynch Syndrome-Associated Colon cancer.
Wang P; Zhong W; Huang Q; Zhu Y; Chen L; Ye K
ACS Biomater Sci Eng; 2024 May; 10(5):3136-3147. PubMed ID: 38663028
[TBL] [Abstract] [Full Text] [Related]
17. Microenvironment, systemic inflammatory response and tumor markers considering consensus molecular subtypes of colorectal cancer.
Jakab A; Patai ÁV; Darvas M; Tormássi-Bély K; Micsik T
Pathol Oncol Res; 2024; 30():1611574. PubMed ID: 38645565
[No Abstract] [Full Text] [Related]
18. Clinicopathological characteristics of Lynch-like syndrome.
Nakamori S; Takao M; Takao A; Natsume S; Iijima T; Kojika E; Nakano D; Kawai K; Inokuchi T; Fujimoto A; Urushibara M; Horiguchi SI; Ishida H; Yamaguchi T
Int J Clin Oncol; 2024 Jul; 29(7):944-952. PubMed ID: 38642190
[TBL] [Abstract] [Full Text] [Related]
19.
Sun M; Moquet J; Barnard S; Mancey H; Burling D; Baldwin-Cleland R; Monahan K; Latchford A; Lloyd D; Bouffler S; Badie C; Anyamene NA; Ainsbury E
Front Public Health; 2024; 12():1369201. PubMed ID: 38638480
[TBL] [Abstract] [Full Text] [Related]
20. Outcomes of 10 years of PSA screening for prostate cancer in Norwegian men with Lynch syndrome.
Grindedal EM; Zucknick M; Stormorken A; Rønne E; Tandstad NM; Isaacs WB; Axcrona K; Mæhle L
Prostate; 2024 Jul; 84(10):945-953. PubMed ID: 38629217
[TBL] [Abstract] [Full Text] [Related]
[Next]
